Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Edwards Lifesciences
EW
Segment Reporting Other Item Amount
Segment Reporting Other Item Amount at other companies
CONMED
CNMD
$6.23M
+6.4%
Century Communities
CCS
$22.22M
+279%
EyePoint, Inc.
EYPT
$4.06M
+16.7%
Essential Utilities
WTRG
-$75K
+74.4%
Radiant Logistics
RLGT
-$271K
-113%
Equitable Holdings
EQH
$371M
-5.1%
Segments
By segment
See full
Europe
$41.9M
+605%
Rest of World
-$7.5M
+18.5%
Japan
-$6M
-30.4%
United States
$800K
+33.3%
Other financials
Income statement
See full
Revenue
$1.6B
+16.7%
Gross profit
$1.3B
+15.7%
Operating income
$477.6M
+21.0%
Net income
$380.7M
+6.3%
EPS (diluted)
$0.66
+8.2%
Balance sheet
See full
Cash & equivalents
$2.4B
-22.3%
Total debt
$702.9M
+0.5%
Total equity
$10.3B
+2.0%
Total assets
$13.3B
+2.3%
Cash flow
See full
Operating cash flow
$43.8M
-84.4%
CapEx
$64.9M
+15.9%
Free cash flow
-$21.1M
-109%
Valuation
See full
Market cap
$51.66B
+19.3%
Enterprise value
$49.92B
+22.2%
P/E
47.1×
+36.8×
P/S
8.2×
+0.4×
Profitability
See full
Gross margin
77.9%
-1.6pp
Operating margin
21.4%
-4.4pp
Net margin
17.4%
-58.3pp
FCF margin
17.3%
—
Returns & leverage
See full
Return on equity
10.7%
-37.8pp
Debt / equity
0.1×
0.0×
Current ratio
4.4×
0.0×